Table: Phoenixbio -2024/25 group results

PhoenixBio

15/05/2025 07:41

May 15 (Reuters)- 
          Phoenixbio Co., Ltd. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended       Year to       NEXT   
               Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                  LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS          RESULTS       FORECAST    H1 FORECAST 
  Sales            1.54            1.72           1.76        895 mln   
               (-10.1 pct)      (-19.2 pct)    (+14.1 pct)  (+13.6 pct) 
  Operating    loss 142 mln       11 mln         167 mln       76 mln   
                                (-97.8 pct)                             
  Recurring    loss 151 mln       43 mln         168 mln       77 mln   
                                (-91.5 pct)                             
  Net
  Net          loss 445 mln       26 mln         161 mln       73 mln   
                                (-94.7 pct)                             
  EPS        loss 110.18 yen     6.98 yen       39.87 yen    18.15 yen  
  Ann Div          NIL              NIL            NIL                  
  -Q2 Div          NIL              NIL            NIL                  
  -Q4 Div          NIL              NIL            NIL                  
  
  NOTE - Phoenixbio Co., Ltd..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T